Change in Serum IgE Levels Following Surgery in Patients with Allergic Fungal Rhinosinusitis is Predictive of Disease Status

Year 2021, Volume: 4 Issue: 2, 58 - 61, 30.08.2021

Vandana Aravind Nedha Joy Thenmozhi Mani Vedantam Rupa

https://izlik.org/JA48AU77AC

Abstract

Objective: We aimed to correlate post-operative endoscopic disease status and reduction in serum total IgE levels in patients with allergic fungal rhinosinusitis (AFRS) and to ascertain whether this reduction has prognostic significance.

Material and Methods: A prospective cohort of 50 patients with biopsy-proven AFRS underwent preoperative endoscopy and serum total IgE assessment. Following endoscopic excision of polyps and allergic mucin and postoperative steroid therapy, patients were re-evaluated at 3-6 months with nasal endoscopy with Kupferberg staging and serum total IgE levels.

Results: There were 27 (54%) male and 23 (46%) female patients. Preoperative endoscopy showed grade 3 polyps in 33 (66%) patients and grade 2 polyps in 17 (34%) patients. Post-operatively, 37 (74%) patients had Stage 0, 11 (22%) had Stage 1, and two (4%) had Stage 2 diseases. Preoperative IgE levels ranged from 153.2 to 6,548.2 IU mL 1. Post operative IgE levels were reduced in 42 of 50 (84%) patients and ranged from 79.9 to 3,900 IU mL 1. There was a negative correlation between percentage change in IgE and post-operative endoscopic score, which was significant (r¼ 0.25; P¼ .032). Based on receiver operating characteristic analysis, a percentage reduction in IgE of 32% had a sensitivity of 69.2% (95% CI: 38.6-90.9) and specificity of 67.6% (95% CI: 50.2-82.0) in predicting endoscopic stage.

Conclusion: Post-operative reduction in serum total IgE levels negatively correlates with endoscopic stage in AFRS patients who undergo surgery and post-operative steroid therapy. A cutoff of 32% in change in IgE levels is predictive of endoscopic Stage 0 disease.

Keywords

Immunoglobulin E , rhinosinusitis , fungal allergy , chronic rhinosinusitis with nasal polyps

References

• Bent JP, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1994;111:580-588.
• Rupa V, Jacob M, Mathews MS, Job A, Kurien M, Chandi SM. Clinicopathological and mycological spectrum of allergic fungal sinusitis in South India. Mycoses. 2002;45:364-367.
• Manning SC, Mabry RL, Schaefer SD, Close LG. Evidence of IgE-mediated hypersensitivity in allergic fungal sinusitis. Laryngoscope. 1993;103:717-721.
• Kupferberg SB, Bent JP, Kuhn FA. Prognosis for allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1997;117:35-41.
• Schubert MS, Goetz DW. Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis. J Allergy Clin Immunol. 1998;102:387-394.
• Stewart AE, Hunsaker DH. Fungus-specific IgG and IgE in allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg. 2002;127:324-332.
• Collins M, Nair S, Smith W, Kette F, Gillis D, Wormald PJ. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope. 2004;114:1242-1246.
• Rupa V, Jacob M, Mathews MS, Seshadri MS. A prospective, randomised, placebo-controlled trial of postoperative oral steroid in allergic fungal sinusitis. Eur Arch Otorhinolaryngol. 2010;267:233-238.
• Marple BF, Mabry RL. Allergic fungal sinusitis: Learning from our failures. Am J Rhinol. 2000;14:223-226.
• Marple BF. Allergic fungal rhinosinusitis: Current theories and management strategies. Laryngoscope. 2001;111:1006-1019.
• Ricketti AJ, Greenberger PA, Patterson R. Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 1984;74:68-71.